OSR Health, Inc.
OSR Health, Inc.
No insider data available
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Related Party | - | - | - | - | - | - | 2 | - | - | - | 2 | - | |||||
Assets | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 1 | 2 | 2 | 2 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Accounts And Other Receivables Net Current | 0 | 0 | 0 | 1 | 1 | 1 | 1 | - | - | - | - | - | |||||
Inventory Net | 1 | 0 | 0 | 0 | 0 | 1 | 1 | - | - | - | - | - | |||||
Assets Current | |||||||||||||||||
Assets Current | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 0 | 0 | 0 | 0 | 0 | |||||
Other Receivables Net Current | - | - | 0 | - | - | - | 0 | - | - | - | - | - | |||||
Prepaid Taxes | 0 | 0 | 0 | 0 | - | 0 | 0 | - | - | - | - | - | |||||
Prepaid Expense Current | - | - | 0 | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | |||||
Assets Held In Trust Noncurrent | - | - | - | - | - | - | 2 | 21 | 20 | 37 | 37 | 72 | |||||
Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | |||||
Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | |||||
Intangible Assets Net Excluding Goodwill | 134 | 139 | 142 | 148 | 156 | 146 | 148 | - | - | - | - | - | |||||
Accounts Payable And Accrued Liabilities Current | - | - | - | - | - | - | 3 | 1 | 1 | 2 | 1 | 1 | |||||
Goodwill | 29 | 30 | 25 | 26 | 26 | 24 | 24 | 27 | 27 | 27 | - | - | |||||
Accrued Income Taxes Current | - | - | - | - | - | - | 0 | 0 | 0 | 1 | 1 | 0 | |||||
Sales And Excise Tax Payable Current | - | - | - | - | - | - | 1 | 1 | 1 | 0 | 0 | - | |||||
Notes Payable Current | - | - | - | - | - | - | - | 2 | 1 | 0 | 0 | 0 | |||||
Deferred Income Tax Assets Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | |||||
Assets | 167 | 172 | 171 | 177 | 185 | 175 | 175 | 21 | 21 | 37 | 37 | 72 | |||||
Stockholders Equity Inclu… | |||||||||||||||||
Preferred Stock Value | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | - | |||||
Short Term Borrowings | 2 | 2 | 2 | 2 | 2 | 2 | 2 | - | - | - | - | - | |||||
Convertible Notes Payable Current | - | - | - | - | - | - | 1 | - | - | - | - | - | |||||
Liabilities And Stockhold… | |||||||||||||||||
Accounts Payable And Other Accrued Liabilities Cur… | 8 | 8 | 8 | 8 | 8 | 7 | 1 | - | - | - | - | - | |||||
Accrued Liabilities Current | 1 | 1 | 1 | 1 | 1 | 1 | 0 | - | - | - | - | - | |||||
Liabilities Current | |||||||||||||||||
Liabilities Current | 16 | 18 | 17 | 15 | 16 | 14 | 3 | 4 | 3 | 3 | 2 | 1 | |||||
Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | |||||
Temporary Equity Carrying Amount Attributable To P… | - | - | - | - | - | - | 2 | - | - | - | 36 | - | |||||
Other Liabilities Current | 1 | 1 | 1 | 1 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Taxes Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | |||||
Derivative Liabilities Current | - | 2 | 3 | 1 | - | - | - | - | - | - | - | - | |||||
Long Term Debt Current | 0 | 0 | - | - | 1 | 0 | - | - | - | - | - | - | |||||
Long Term Debt Noncurrent | 0 | 0 | - | 0 | - | 0 | 0 | - | - | - | - | - | |||||
Operating Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | |||||
Other Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | |||||
Deferred Income Tax Liabilities Net | 26 | 27 | 27 | 28 | 30 | 28 | 28 | - | - | - | - | - | |||||
Temporary Equity Shares Issued | - | - | - | - | - | - | 0 | - | - | - | 3 | - | |||||
Liabilities | 42 | 45 | 44 | 43 | 46 | 42 | 32 | 6 | 5 | 5 | 4 | 3 | |||||
Commitments And Contingen… | |||||||||||||||||
Temporary Equity Shares Outstanding | - | - | - | - | - | - | 0 | - | - | - | 3 | - | |||||
Temporary Equity Redemption Price Per Share | - | - | - | - | - | - | 11.21 | - | - | - | 10.5 | - | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | - | - | - | - | - | - | - | 0 | 0 | 0 | - | - | |||||
Additional Paid In Capital Common Stock | 147 | 146 | 111 | 110 | 107 | 106 | 163 | - | - | - | - | - | |||||
Stockholders Equity | |||||||||||||||||
Preferred Stock Par Or Stated Value Per Share | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Stockholders Equity | 125 | 127 | 127 | 134 | 139 | 132 | 143 | -6 | 90 | -4 | -4 | -2 | |||||
Retained Earnings Accumulated Deficit | -41 | -40 | -37 | -32 | -30 | -31 | -19 | -6 | -5 | -4 | -4 | -2 | |||||
Preferred Stock Shares Authorized | - | - | - | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Preferred Stock Shares Issued | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -2 | -2 | 4 | 5 | 7 | 0 | -0 | - | - | - | - | - | |||||
Minority Interest | 21 | 24 | 49 | 52 | 55 | 57 | - | - | - | - | - | - | |||||
Liabilities And Stockholders Equity | 167 | 172 | 171 | 177 | 185 | 175 | 175 | 21 | 21 | 37 | 37 | 72 | |||||
Allowance For Doubtful Accounts Receivable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 5,000 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | |||||
Common Stock Shares Issued | 35 | 33 | 27 | 24 | 20 | 19 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Shares Outstanding | 35 | 33 | 27 | 24 | 20 | 19 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -37.12% | -47.97% | -27.39% | - | - | - | - | - | - | - | - | - |
| 2025 | 22.61% | 2.61% | -47.48% | 10.36% | 17.08% | 30.13% | 24.58% | -0.17% | -1.02% | 14.93% | -16.75% | -34.99% |
| 2024 | -0.09% | 0.28% | 0.65% | 0.93% | 0.88% | 2.22% | -5.31% | -7.35% | -7.35% | -12.69% | 5.22% | -11.94% |
| 2023 | - | - | - | - | - | - | 0.00% | 0.38% | 1.34% | 2.06% | 0.56% | 0.94% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 0.18 | 0.16 | 0.16 | 0.21 | 0.18 | 0.25 | 0.67 | 0.01 | 0.05 | 0.02 | 0.01 | 0.07 | |||||
| Quick Ratio | 0.14 | 0.14 | 0.14 | 0.20 | 0.17 | 0.20 | 0.40 | 0.00 | 0.03 | 0.00 | 0.01 | 0.05 | |||||
| Working Capital | -12.87M | -14.97M | -14.35M | -11.83M | -12.98M | -10.42M | -1.14M | -3.90M | -3.25M | -2.68M | -2.02M | -1.02M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.33 | 0.35 | 0.35 | 0.32 | 0.33 | 0.32 | 0.22 | 0.07 | 0.06 | 0.03 | -1.05 | -1.29 | |||||
| Interest Coverage TTM | -34.00 | -36.63 | -36.22 | -109.56 | -149.65 | -208.67 | -308.88 | -917.35 | -3,188.17 | -55,008.48 | - | - | |||||
| Debt Ratio | 0.25 | 0.26 | 0.26 | 0.24 | 0.25 | 0.24 | 0.18 | 0.29 | 0.27 | 0.13 | 0.11 | 0.04 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.01 | 0.02 | 0.02 | 0.05 | 0.05 | 0.05 | 0.05 | 0.06 | 0.04 | 0.02 | 0.00 | 0.00 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -0.60 | -0.54 | -1.20 | -0.81 | -1.04 | -1.68 | -4.79 | -1.47 | -1.14 | -0.54 | 0.05 | 0.05 | |||||
| Free Cash Flow Per Share TTM | -0.23 | -0.21 | -0.35 | -0.26 | -0.17 | -0.24 | -0.86 | -0.48 | -0.28 | -0.23 | -0.11 | -0.06 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 35.29% | 22.24% | 20.40% | 11.91% | 9.96% | 14.31% | 15.24% | - | - | - | - | - | |||||
| Operating Profit Margin TTM | -933.75% | -726.07% | -631.01% | -259.25% | -245.56% | -218.57% | -219.68% | -385.43% | -363.42% | -362.83% | - | - | |||||
| Net Profit Margin TTM | -1,102.02% | -707.50% | -931.19% | -357.84% | -290.35% | -355.01% | -194.07% | -227.53% | -314.77% | -336.39% | - | - | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | -66.67% | -49.19% | -45.40% | 100.07% | 202.84% | 468.37% | - | - | - | - | - | - | |||||
| Net Income Growth (1Y) | 26.50% | 1.26% | 161.97% | 214.65% | 179.35% | 499.84% | -2,658.05% | -1,314.40% | - | - | - | - | |||||
| EPS Growth (1Y) | -41.71% | -64.62% | -71.07% | -26.82% | -8.85% | 209.26% | -9,226.21% | -2,821.06% | - | - | - | - | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -0.52 | -1.01 | -0.41 | -0.50 | -1.33 | -1.12 | -2.41 | -7.40 | -9.43 | -19.58 | 199.93 | 192.21 | |||||
| P/B TTM | 0.08 | 0.15 | 0.09 | 0.07 | 0.15 | 0.15 | 0.17 | 0.50 | 0.59 | 0.40 | -20.66 | -38.36 | |||||
| P/S TTM | 5.75 | 7.16 | 3.79 | 1.78 | 3.85 | 3.96 | 4.67 | 16.83 | 29.69 | 65.85 | - | - | |||||
| Market Cap | 10.39M | 18.82M | 11.01M | 9.30M | 20.91M | 20.50M | 24.85M | 44.01M | 53.21M | 59.94M | 80.73M | 94.17M | |||||
| Enterprise Value | 11.54M | 19.95M | 11.63M | 8.98M | 21.73M | 21.06M | 27.60M | 45.26M | 54.21M | 59.56M | 80.71M | 94.31M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -7.49M | -6.48M | -6.73M | -4.59M | -2.55M | -2.61M | -1.85M | -1.95M | -1.40M | -1.27M | -818.77K | -539.27K | |||||
| Net Debt | 1.14M | 1.13M | 623.20K | -317.41K | 816.56K | 552.00K | 2.76M | 1.26M | 1.00M | -377.44K | -15.42K | 142.05K | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
OSR Health, Inc. (OSRH) — SEC Financial Statements & Analysis
OSR Health, Inc. (OSRH) is a surgical & medical instruments & apparatus company, incorporated in DE. OSR Health, Inc. trades on Nasdaq as: OSRH, OSRHW. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), OSR Health, Inc. reported a -66.67% year-over-year revenue growth, a Gross Profit Margin of 35.29% (TTM), a Debt-to-Equity ratio of 0.33x, a Price-to-Sales (P/S) ratio of 5.75x (TTM), a Price-to-Book (P/B) ratio of 0.08x (TTM), at a market cap of $10.39M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -66.67%
- Gross Profit Margin TTM
- 35.29%
- Debt To Equity
- 0.33x
- P/S TTM
- 5.75x
- P/B TTM
- 0.08x
- Market Cap
- $10.39M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is OSR Health, Inc. in?
OSR Health, Inc. (OSRH) operates in the Surgical & Medical Instruments & Apparatus industry.
What is OSRH's market cap?
OSR Health, Inc. (OSRH) has a market capitalization of $10.39M as of 2026-06-30.
What exchange does OSRH trade on?
OSR Health, Inc. (OSRH) trades on the Nasdaq.
Where is OSR Health, Inc. incorporated?
OSR Health, Inc. is incorporated in DE.